Rachel M. Shaffer

Rachel M. Shaffer

Auto-generated profile, based on publicly available information

Rachel M. Shaffer

Center for Public Health and Environmental Assessment, Office of Research and Development, US EPA, DC, Washington, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2019 in Environmental Health
Verified
Journal Article
Open access
PDF file
CGChristina Gillezeau
Christina Gillezeau
Maaike van GerwenMaaike van Gerwen
Maaike van Gerwen
RSRachel M. Shaffer
Rachel M. Shaffer
IRIemaan Rana
Iemaan Rana
LZLuoping Zhang
Luoping Zhang
emanuela taioliemanuela taioli
emanuela taioli
Despite the growing and widespread use of glyphosate, a broad-spectrum herbicide and desiccant, very few studies have evaluated the extent and amount of human exposure. We review documented levels of human exposure among workers in occupational settings and the general population. We conducted a review of scientific publications on glyphosate levels in humans; 19 studies were identified, of which five investigated occupational exposure to glyphosate, 11 documented the exposure in general populations, and three reported on both. Eight studies reported urinary levels in 423 occupationally and para-occupationally exposed subjects; 14 studies reported glyphosate levels in various biofluids on 3298 subjects from the general population. Average urinary levels in occupationally exposed subjects varied from 0.26 to 73.5 μg/L; environmental exposure urinary levels ranged from 0.16 to 7.6 μg/L. Only two studies measured temporal trends in exposure, both of which show increasing proportions of individuals with detectable levels of glyphosate in their urine over time. The current review highlights the paucity of data on glyphosate levels among individuals exposed occupationally, para-occupationally, or environmentally to the herbicide. As such, it is challenging to fully understand the extent of exposure overall and in vulnerable populations such as children. We recommend further work to evaluate exposure across populations and geographic regions, apportion the exposure sources (e.g., occupational, household use, food residues), and understand temporal trends.

1 November 2015 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
KJKimberly A. Jarema
Kimberly A. Jarema
DHDeborah L. Hunter
Deborah L. Hunter
RSRachel M. Shaffer
Rachel M. Shaffer
MBMamta Behl
Mamta Behl
SPStephanie Padilla
Stephanie Padilla

1 August 2018 in Pediatrics
Verified
Journal Article
Open access
PDF file
LTLeonardo Trasande
Leonardo Trasande
RSRachel M. Shaffer
Rachel M. Shaffer
SSSheela Sathyanarayana
Sheela Sathyanarayana
CHCOUNCIL ON ENVIRONMENTAL HEALTH
COUNCIL ON ENVIRONMENTAL HEALTH
JLJennifer A. Lowry
Jennifer A. Lowry
AWAlan D. Woolf
Alan D. Woolf
Increasing scientific evidence suggests potential adverse effects on children’s health from synthetic chemicals used as food additives, both those deliberately added to food during processing (direct) and those used in materials that may contaminate food as part of packaging or manufacturing (indirect). Concern regarding food additives has increased in the past 2 decades in part because of studies that increasingly document endocrine disruption and other adverse health effects. In some cases, exposure to these chemicals is disproportionate among minority and low-income populations. This report focuses on those food additives with the strongest scientific evidence for concern. Further research is needed to study effects of exposure over various points in the life course, and toxicity testing must be advanced to be able to better identify health concerns prior to widespread population exposure. The accompanying policy statement describes approaches policy makers and pediatricians can take to prevent the disease and disability that are increasingly being identified in relation to chemicals used as food additives, among other uses.

1 February 2019 in Environment International
Verified
Journal Article
Open access
RSRachel M. Shaffer
Rachel M. Shaffer
Kelly K. FergusonKelly K. Ferguson
Kelly K. Ferguson
LSLianne Sheppard
Lianne Sheppard
TJTamarra James-Todd
Tamarra James-Todd
SBSamantha Butts
Samantha Butts
SSSheela Sathyanarayana
Sheela Sathyanarayana
Phthalates are common plasticizer chemicals that have been linked to glucose intolerance in the general population, but there is only limited research on their association with gestational diabetes (GDM). We evaluated the association between 11 urinary phthalate metabolites and GDM, impaired glucose tolerance (IGT), and continuous blood glucose concentration during pregnancy in The Infant Development and Environment Study (TIDES). Based on prior study results, our primary analyses focused on monoethyl phthalate (MEP) in relation to our outcomes of interest. We used multi-variable logistic regression to examine the odds of GDM and IGT in relation to an interquartile-range (IQR) increase in natural log (ln)-transformed, specific gravity (SG)-adjusted first trimester (T1) and average of T1 and third trimester (T3) ("T1T3avg") phthalate metabolite concentrations. We fit linear regression models to examine the percent change in blood glucose per IQR increase in ln-transformed, SG-adjusted T1 and T1T3avg phthalates. In sensitivity analyses, we examined interactions between exposure and race. We adjusted for maternal age, maternal body mass index, study center, race/ethnicity, parity, and gestational age at glucose testing. In our sample of 705 pregnant women, we observed 60 cases of GDM, 90 cases of IGT, and an average GLT blood glucose of 113.6 ± 27.7 mg/dL. In our primary analysis, T1T3avg MEP was positively associated with GDM ([OR (95% CI) per IQR increase] T1T3avg MEP: 1.61 (1.10, 2.36)). In secondary analyses, most other phthalates were not found to be related to study outcomes, though some associations were noted. Sensitivity analyses indicated possible strong race-specific associations in Asians, though these results are based on a small sample size (n = 35). In alignment with our a priori selection, we documented an association between T1T3avg MEP and GDM. Additional phthalate metabolites were also found to be linked to glucose intolerance, with possible stronger associations in certain racial/ethnic subgroups. Given the prevalence of phthalate exposures and the growing evidence of associations with metabolic outcomes, future studies should continue to examine this question in diverse cohorts of pregnant women, particularly in those who may be at higher risk for GDM and IGT.

23 July 2018 in Pediatrics
Verified
Journal Article
Open access
PDF file
LTLeonardo Trasande
Leonardo Trasande
RSRachel M. Shaffer
Rachel M. Shaffer
SSSheela Sathyanarayana
Sheela Sathyanarayana
CHCOUNCIL ON ENVIRONMENTAL HEALTH
COUNCIL ON ENVIRONMENTAL HEALTH
Our purposes with this policy statement and its accompanying technical report are to review and highlight emerging child health concerns related to the use of colorings, flavorings, and chemicals deliberately added to food during processing (direct food additives) as well as substances in food contact materials, including adhesives, dyes, coatings, paper, paperboard, plastic, and other polymers, which may contaminate food as part of packaging or manufacturing equipment (indirect food additives); to make reasonable recommendations that the pediatrician might be able to adopt into the guidance provided during pediatric visits; and to propose urgently needed reforms to the current regulatory process at the US Food and Drug Administration (FDA) for food additives. Concern regarding food additives has increased in the past 2 decades, in part because of studies in which authors document endocrine disruption and other adverse health effects. In some cases, exposure to these chemicals is disproportionate among minority and low-income populations. Regulation and oversight of many food additives is inadequate because of several key problems in the Federal Food, Drug, and Cosmetic Act. Current requirements for a “generally recognized as safe” (GRAS) designation are insufficient to ensure the safety of food additives and do not contain sufficient protections against conflict of interest. Additionally, the FDA does not have adequate authority to acquire data on chemicals on the market or reassess their safety for human health. These are critical weaknesses in the current regulatory system for food additives. Data about health effects of food additives on infants and children are limited or missing; however, in general, infants and children are more vulnerable to chemical exposures. Substantial improvements to the food additives regulatory system are urgently needed, including greatly strengthening or replacing the “generally recognized as safe” (GRAS) determination process, updating the scientific foundation of the FDA’s safety assessment program, retesting all previously approved chemicals, and labeling direct additives with limited or no toxicity data.

1 April 2017 in Toxicology in Vitro
Verified
Journal Article
Closed access
SCShih-Yu Chang
Shih-Yu Chang
JVJenna L. Voellinger
Jenna L. Voellinger
KNKirk P. Van Ness
Kirk P. Van Ness
BCBrian Chapron
Brian Chapron
RSRachel M. Shaffer
Rachel M. Shaffer
David L. EatonDavid L. Eaton
David L. Eaton